Responding to Real-World Data Guidance, Industry Calls for Flexibility and Further Clarity
March 31, 2022
Commenters praised the FDA’s recent draft guidance on using electronic health records (EHR) and medical claims data in trials, but they hope the agency will acknowledge issues inherent to real-world data (RWD), offer clarity in certain areas and be flexible as sponsors and sites adjust to the new recommendations.